298Indexed trials
mesh condition
Dementia
Intelligence
Dementia intelligence: 298 indexed trials, 65 recruiting studies, 227 sponsors across 54 countries.
65Recruiting
227Sponsors
54Countries
Leading sponsors
Massachusetts General Hospital61 recruiting
Johns Hopkins University53 recruiting
Washington University School of Medicine53 recruiting
University of California, Los Angeles40 recruiting
National Taiwan University Hospital30 recruiting
Oregon Health and Science University30 recruiting
Radboud University Medical Center30 recruiting
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.30 recruiting
National Institute of Mental Health (NIMH)31 recruiting
Emory University30 recruiting
Indiana University31 recruiting
Chinese University of Hong Kong30 recruiting
Geographic activity
United States142trials
Canada32trials
France28trials
United Kingdom28trials
Spain22trials
Australia19trials
Netherlands16trials
Italy15trials
Germany14trials
Taiwan8trials
South Korea7trials
Belgium7trials
Leading interventions
Donepezil5trials
galantamine hydrobromide3trials
Risperidone3trials
Escitalopram3trials
MRI2trials
Music2trials
Neuroimaging2trials
F 18 T8072trials
Citalopram2trials
Exercise2trials
Flutemetamol F18 Injection2trials
E20202trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.